Characterization of phage-displayed recombinant anti-idiotypic antibody fragments against coronavirus-neutralizing monoclonal antibodies

Viral Immunology

Volumn 10, Issue 4, 1997, Pages 175-182

  Lamarre, Alain ^a   Talbot, Pierre J ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; VIRUS ANTIBODY;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CORONAVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PHAGE DISPLAY;

ANIMALIA; CORONAVIRUS; MURINAE; RNA VIRUSES;

EID: 0031406872     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1997.10.175     Document Type: Article

References (27)

1. Anders E.M., G.P. Kapaklis-Deliyannis, and D.O. White. 1989. Induction of immune response to influenza virus with anti-idiotypic antibodies. J. Virol. 63:2758-2767.
2. Brack, C., M.S. Co, M. Slaoui, G.N. Gaulton, T. Smith, B.N. Fields, J.I. Mullins, and M.I. Greene. 1986. Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen. Proc. Natl. Acad. Sci. USA 83:6578-6582.
3. Collins, A.R., R.L. Knobler, H. Powell, and M.J. Buchmeier. 1982. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology 119:358-371.
4. Daniel, C., and P.J. Talbot. 1990. Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59. Virology 174:87-94.
5. Daniel, C., R. Anderson, M.J. Buchmeier, J.O. Fleming, W.J.M. Spaan, H. Wege, and P.J. Talbot. 1993. Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronaviras spike glycoprotein and evidence that it forms part of a complex tridimensional structure. J. Virol. 67:1185-1194.
6. De la Cruz, V.F., A.A. Lal, and T.F. McCutchan. 1988. Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage. J. Biol. Chem. 263:4318-4322.
7. Griffiths, A.D., S.C. Williams, O. Hartley, I.M. Tomlinson, P. Waterhouse, W.L. Crosby, R.E. Kontermann, P.T. Jones, N.M. Low, T.J. Allison, T.D. Prospero, H.R. Hoogenboom, A. Nissim, J.P.L. Cox, J.L. Harrison, M. Zaccolo, E. Gherardi, and G. Winter. 1994. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13:3245-3260.
8. Grzych, J.M., M. Capron, P.H. Lambert, C. Dissous, S. Torres, and A. Capron. 1985. An anti-idiotype vaccine against experimental schistosomiasis. Nature 316:74-76.
9. H gene segments rearranged in vitro. J. Mol. Biol. 227:381-388.
10. Jerne, N.K. 1974. Towards a network theory of the immune system. Ann. Immunol. 125C:373-389.
11. Kennedy, R.C., J.W. Eichberg, R.E. Lanford, and G.R. Dreesman. 1986. Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science 232:220-223.
12. Lamarre, A., J. Lecomte, and P.J. Talbot. 1991. Antiidiotypic vaccination against murine coronavirus infection. J. Immunol. 147:4256-4262.
13. Luytjes, W., L.S. Sturman, P.J. Bredenbeek, J. Charite, B.A.M. van der Zeijst, M.C. Horzinek, and W.J.M. Spaan. 1987. Primary structure of the glycoprotein E2 of coronaviras MHV-A59 and identification of the trypsin cleavage site. Virology 161:479-487.
14. McNamara, M.K., R.E. Ward, and H. Kohler. 1984. Monoclonal idiotope vaccine against Streptococcus pneumoniae infection. Science 226:1325-1326.
15. Nissim, A., H.R. Hoogenboom, I.M. Tomlinson, G. Flynn, C. Midgley, D. Lane, and G. Winter. 1994. Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J. 13:692-698.
16. Reagan, K.J., W.H. Wunner, T.J. Wiktor, and H. Koprowski. 1983. Anti-idiotypic antibodies induce neutralizing antibodies to rabies virus glycoprotein. J. Virol. 48:660-666.
17. Sacks, D.L., and A. Sher. 1983. Evidence that anti-idiotype induced immunity to experimental african trypanosomiasis is genetically restricted and requires recognition of combining site-related idiotopes. J. Immunol. 131:1511-1515.
18. Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
19. Spaan, W., D. Cavanagh, and M.C. Horzinek. 1990. Coronaviruses, Pp. 359-379. In: M.H.V. van Regenmortel, and A.R. Neurath (eds.): Immunochemistry of viruses. The basis for serodiagnosis and vaccines, Vol. 2. Elsevier Science Publishers B.V., Amsterdam.
20. Stein, K.E., and T. Söderström. 1984. Neonatal administration of idiotype or antiidiotype primers for protection against Escherichia coli K13 infection in mice. J. Exp. Med. 160:1001-1011.
21. H segments with different hypervariable loops. J. Mol. Biol. 227:776-798.
22. Uytdehaag, F.G.C.M., and A.D.M.E. Osterhaus. 1985. Induction of neutralizing antibody in mice against poliovirus type II with monoclonal anti-idiotypic antibody. J. Immunol. 134:1225-1229.
23. Wege, H., St. Siddell, and V. ter Meulen. 1982. The biology and pathogenesis of coronaviruses. Curr. Top. Microbiol. Immunol. 99:165-200.
24. Williams, R.K., G.S. Jiang, and K.V. Holmes. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88:5533-5536.
25. Yu, M., and P.J. Talbot. 1995. Induction of a protective immune response to murine coronavirus with non-internal image anti-idiotypic antibodies. Pp. 165-172. In: P.J. Talbot, and G.A. Levy (eds): In Corona- and related viruses. Current concepts in molecular biology and pathogenesis. Plenum Press, New York.
26. Yu, M.W.N., S. Lemieux, and P.J. Talbot. 1996. Genetic control of anti-idiotypic vaccination against coronavirus infection. Eur. J. Immunol. 26:3230-3233.
27. Zaghouani, H., S.A. Anderson, K.E. Sperber, C. Daian, R.C. Kennedy, L. Mayer, and C.A. Bona. 1995. Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. Proc. Natl. Acad. Sci. USA 92:631-635.